Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
FDA Extends Review Period For Regeneron's COVID-19 Antibody Therapy
April 14, 2022
Tickers
REGN
RHHBY
Tags
Benzinga
COVID/19 Coronavirus
General
From
Benzinga
Volume Springs Back Into The OTC Markets In March – Take A Look At Some Of The Top Movers
April 14, 2022
Tickers
ABML
ADDYY
BNPQY
CLNV
Tags
BNPQY
ABML
EXPGY
From
Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
April 13, 2022
Tickers
PLRX
RHHBF
RHHBY
RHHVF
Tags
Analyst Ratings
PLRX
RHHBF
From
Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
April 13, 2022
Tickers
AFMD
ALZN
ATRS
CRDF
Tags
SRRA
Small Cap
Penny Stocks
From
Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
Tickers
BNTX
GMAB
MTNB
PFE
Tags
MTNB
GMAB
BNTX
From
Benzinga
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Tickers
AZN
BIIB
ENTX
GLSI
Tags
ENTX
BIIB
GLSI
From
InvestorPlace
SoftBank Loses Vision Fund Leader; Continues To Liquidate Portfolio
April 04, 2022
Tickers
RHHBY
SFTBF
SFTBY
TECH
Tags
News
Briefs
Media
From
Benzinga
Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis
April 04, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
Biotech
RHHBF
From
Benzinga
FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults
April 04, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Benzinga
General
FDA
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
AXSM
MRNS
AMRX
From
Benzinga
Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial
March 30, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
General
Phase 3 Trial
From
Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
March 30, 2022
Tickers
ADGI
ADMP
AFMD
AMLX
Tags
ADGI
SPRO
IBB
From
Benzinga
Drug makers, Scientists Working For Long COVID Treatments: Reuters
March 25, 2022
Tickers
AXLA
GSK
HGEN
MRNA
Tags
RHHVF
Health Care
HGEN
From
Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
Tickers
ANTX
ATHA
BMY
CODX
Tags
TFFP
Benzinga
News
From
Benzinga
Why Are ImmunoGen Shares Trading Lower Today
March 21, 2022
Tickers
IMGN
RHHBY
Tags
RHHBY
Health Care
why it's moving
From
Benzinga
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
March 16, 2022
Tickers
PTCT
RHHBF
RHHBY
RHHVF
Tags
General
News
Briefs
From
Benzinga
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
NVS
RHHBY
Recent Press Releases
From
Motley Fool
The OTCQX's Top 10 Experience A Shuffle In February
March 15, 2022
Tickers
ADDYY
ETHE
GBOOY
GBTC
Tags
GBTC
Penny Stocks
Small Cap
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
TCON
RHHBY
ATNX
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
BAYZF
General
News
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Briefs
News
General
From
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Tickers
ACIU
ADAP
ALDX
ALEC
Tags
IMRA
UNH
ALDX
From
Benzinga
OTC Markets 2021 Annual Data Review Highlights A Record 60% $ Volume Increase
March 07, 2022
Tickers
BVNNF
GBTC
OTCM
RHHBY
Tags
OTCM
GBTC
Small Cap
From
Benzinga
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
March 04, 2022
Tickers
AZN
HRTX
JNJ
LEGN
Tags
HRTX
SGEN
AZN
From
Motley Fool
Viatris Just Snagged a Major FDA Approval
March 03, 2022
Tickers
ABBV
NVS
REGN
RHHBY
Tags
RHHBY
NVS
VTRS
From
Motley Fool
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers
BMY
EXEL
ICPT
RHHBY
Tags
RHHBY
BMY
XBI
From
Motley Fool
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Tickers
AZN
AZNCF
RHHBY
TAK
Tags
TAK
General
News
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
RHHBY
RHHVF
REGN
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
GOOG
Recent Press Releases
Market News
From
Motley Fool
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Tickers
BNPQY
CYDY
EEENF
ETHE
Tags
BNPQY
LIACF
Partner Content
From
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.